Radmanesh F, Falcone GJ, Anderson CD, et al. Rare Coding Variation and Risk of Intracerebral Hemorrhage. Stroke. 2015;46(8):2299-301. doi:10.1161/STROKEAHA.115.009838
Yoon KW, Byun S, Kwon E, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science. 2015;349(6247):1261669. doi:10.1126/science.1261669
Janiszewska M, Liu L, Almendro V, et al. In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer. Nat Genet. 2015;47(10):1212-9. doi:10.1038/ng.3391
Sanders SJ, He X, Willsey J, et al. Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci. Neuron. 2015;87(6):1215-33. doi:10.1016/j.neuron.2015.09.016
Salo PP, Vaara S, Kettunen J, et al. Genetic Variants on Chromosome 1p13.3 Are Associated with Non-ST Elevation Myocardial Infarction and the Expression of DRAM2 in the Finnish Population. PLoS One. 2015;10(10):e0140576. doi:10.1371/journal.pone.0140576
Vieira NM, Elvers I, Alexander MS, et al. Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype. Cell. 2015;163(5):1204-13. doi:10.1016/j.cell.2015.10.049
Shaw AT, Friboulet L, Leshchiner I, et al. Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F. N Engl J Med. 2016;374(1):54-61. doi:10.1056/NEJMoa1508887
Ruggles KV, Tang Z, Wang X, et al. An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer. Mol Cell Proteomics. 2016;15(3):1060-71. doi:10.1074/mcp.M115.056226
Schwieler L, Samuelsson M, Frye MA, et al. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients. J Neuroinflammation. 2016;13(1):51. doi:10.1186/s12974-016-0517-7
Liang J, Cade BE, Wang H, et al. Comparison of Heritability Estimation and Linkage Analysis for Multiple Traits Using Principal Component Analyses. Genet Epidemiol. 2016;40(3):222-32. doi:10.1002/gepi.21957